Pantoprazole Intravenous Infusion Dosing
For adults with GERD and erosive esophagitis, administer pantoprazole 40 mg IV once daily for 7-10 days; for upper GI bleeding with high-risk endoscopic stigmata, use 80 mg IV bolus followed by 8 mg/hour continuous infusion for 72 hours; for Zollinger-Ellison syndrome, start with 80 mg IV every 12 hours. 1
Adult Dosing by Indication
GERD with History of Erosive Esophagitis
- Standard dose: 40 mg IV once daily for 7-10 days 1
- Can be administered as either:
- Transition to oral therapy as soon as patient can tolerate 1
Critical caveat: The FDA label explicitly states that 40 mg once daily does not raise gastric pH sufficiently for life-threatening upper GI bleeds—this dose is inadequate for acute hemorrhage. 1
Acute Upper GI Bleeding (High-Risk Lesions)
- High-dose regimen: 80 mg IV bolus, then 8 mg/hour continuous infusion for 72 hours after endoscopic hemostasis 2
- This represents a class effect applicable to pantoprazole based on omeprazole data 2
- High-risk endoscopic stigmata include: active bleeding, non-bleeding visible vessel, or adherent clot 2, 3
- This regimen reduces rebleeding from 19.8% to 7.8%, decreases transfusion requirements, and shortens hospital stay 3
The 2003 Annals of Internal Medicine consensus guidelines established this as the standard for high-risk peptic ulcer bleeding, demonstrating reduced rebleeding, surgery rates, and mortality in meta-analyses. 2 While the 2024 Critical Care Medicine guidelines recommend low-dose PPI (≤40 mg daily) for stress ulcer prophylaxis in critically ill patients, this explicitly does not apply to active bleeding scenarios. 2
Zollinger-Ellison Syndrome and Pathological Hypersecretion
- Initial dose: 80 mg IV every 12 hours 1
- Target: maintain acid output <10 mEq/hour (<5 mEq/hour if prior acid-reducing surgery) 1, 4
- Dose escalation if needed: 80 mg IV every 8 hours (maximum 240 mg/day) 1, 4
- Onset of acid control occurs within 41 minutes on average; 81% of patients controlled on every-12-hour dosing 4
- Doses >240 mg/day or treatment >6 days have not been studied 1
Stress Ulcer Prophylaxis in ICU
- Low-dose: 40 mg IV once daily 2
- Use only in critically ill adults with risk factors for clinically important stress-related upper GI bleeding 2
- Discontinue when critical illness resolves or risk factors no longer present 2
- Either enteral or IV routes are acceptable 2
Pediatric Dosing
Ages 1 Month to <2 Years
- Real-world safety data available but FDA-approved dosing not explicitly established in label for IV formulation in this age group 5, 6
- Population pharmacokinetic studies suggest clearance is faster in children 6 months to 5 years compared to adults 7
- Weight-tiered dosing achieves >90% of children within target exposure range regardless of obesity status 8
Ages 2-16 Years
- Clearance significantly influenced by: body weight, age, systemic inflammatory response syndrome, hepatic dysfunction, and CYP2C19 inhibitors 7
- Dose reductions needed: 50.5% reduction with hepatic dysfunction, 62.3% with SIRS, 65.8% with CYP2C19 inhibitors 7
Administration Considerations
Compatibility and preparation: 1
- Administer through dedicated line or Y-site
- Flush line before and after with D5W, NS, or lactated Ringer's
- Reconstituted solution stable 6-24 hours at room temperature depending on concentration
- Diluted solution must be used within 24 hours
Common pitfall: Do not use the standard 40 mg once-daily GERD dose for acute GI bleeding—this is the most critical dosing error to avoid, as it provides inadequate acid suppression for hemorrhage control. 1